Search…

Dongyao Pharmaceutical-B (01875.HK) and Pharmaron Alliance (02268.HK) sign technology development and manufacturing service agreement.

17/06/2026

Wiztime Financial News APP, Dongyao Pharmaceutical -B (01875.HK) and Pharmaron (02268) jointly announced that on June 16, 2026, Dongyao Pharmaceutical and Pharmaron BioTech signed a process development and manufacturing service agreement. According to this agreement, Dongyao Pharmaceutical will provide process development and manufacturing services to Pharmaron BioTech.

Latest

2 m ago

In the first quarter, the shipment of smart glasses surged by over 130%. Institutions predict that the net profit of 19 concept stocks will increase by over 30% in the next 3 years.

3 m ago

Leading domestic analog integrated circuit company Shengbang shares (03661) launches Hong Kong IPO, with a luxury cornerstone investor group subscribing for HK$2.296 billion, raising up to approximately HK$4.5 billion.

6 m ago

CICC: Clear signals of the bottoming out in the current real estate market, with the supply side continuing to improve in quality and shrinking in quantity.

7 m ago

Huatai Securities: Expect Bank of Japan to raise interest rates once more this year.

9 m ago

The Federal Reserve will announce its interest rate decision, and observers will carefully examine the forecast numbers in the dot plot, paying attention to whether Powell is involved.

See all latest